中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
21期
1399-1402
,共4页
TFPI-2%恶性肿瘤%凋亡%转移%血管生成
TFPI-2%噁性腫瘤%凋亡%轉移%血管生成
TFPI-2%악성종류%조망%전이%혈관생성
TFPI-2%malignant tumor%apoptosis%metastasis%angiogenesis
组织因子途径抑制物-2(tissue factor pathway inhibitor-2,TFPI-2)是具有库尼(Kunitz)结构域的丝氨酸蛋白酶抑制剂。新近发现,TFPI-2在恶性肿瘤中表达降低,并与肿瘤转移、侵袭等恶性生物学行为密切相关。该分子表达的分子调控机制包括启动子CpG岛超甲基化、ERK1/2信号途径、JNK信号途径等。TFPI-2的主要功能体现在维持肿瘤微环境的稳定性,抑制肿瘤细胞的生长、侵袭和转移。目前认为,TFPI-2在调节细胞增殖、凋亡以及血管生成拟态方面也发挥重要作用。本文就TFPI-2在肿瘤中的表达及调控机制、细胞凋亡、血管生成中作用进行综述,为其在肿瘤的预防、诊断及基因治疗中开展深入研究提供理论基础。
組織因子途徑抑製物-2(tissue factor pathway inhibitor-2,TFPI-2)是具有庫尼(Kunitz)結構域的絲氨痠蛋白酶抑製劑。新近髮現,TFPI-2在噁性腫瘤中錶達降低,併與腫瘤轉移、侵襲等噁性生物學行為密切相關。該分子錶達的分子調控機製包括啟動子CpG島超甲基化、ERK1/2信號途徑、JNK信號途徑等。TFPI-2的主要功能體現在維持腫瘤微環境的穩定性,抑製腫瘤細胞的生長、侵襲和轉移。目前認為,TFPI-2在調節細胞增殖、凋亡以及血管生成擬態方麵也髮揮重要作用。本文就TFPI-2在腫瘤中的錶達及調控機製、細胞凋亡、血管生成中作用進行綜述,為其在腫瘤的預防、診斷及基因治療中開展深入研究提供理論基礎。
조직인자도경억제물-2(tissue factor pathway inhibitor-2,TFPI-2)시구유고니(Kunitz)결구역적사안산단백매억제제。신근발현,TFPI-2재악성종류중표체강저,병여종류전이、침습등악성생물학행위밀절상관。해분자표체적분자조공궤제포괄계동자CpG도초갑기화、ERK1/2신호도경、JNK신호도경등。TFPI-2적주요공능체현재유지종류미배경적은정성,억제종류세포적생장、침습화전이。목전인위,TFPI-2재조절세포증식、조망이급혈관생성의태방면야발휘중요작용。본문취TFPI-2재종류중적표체급조공궤제、세포조망、혈관생성중작용진행종술,위기재종류적예방、진단급기인치료중개전심입연구제공이론기출。
Tissue factor pathway inhibitor-2 (TFPI-2), a member of the Kunitz-type family, is a broad-spectrum serine proteinase inhibitor. The expression of TFPI-2 is inversely related to increasing degree of malignancy, suggesting a role of TFPI-2 in the mainte-nance of tumor stability and inhibition of the growth of neoplasma. Aberrant methylation of TFPI-2 promoter cytosine-phosphorothio-ate-guanine (CpG) islands has been widely documented to be responsible for diminished expression of TFPI-2 mRNA and protein dur-ing cancer progression. TFPI-2 expression is significantly up-regulated by the ERK1/2 and JNK signaling pathways and modestly in-creased by VEGF, TNF-alpha, and fibroblast growth factor in time-and dose-dependent manners. TFPI-2 can maintain the stability of the tumor environment and inhibit invasiveness and growth of neoplasms. TFPI-2 has also been shown to regulate proliferation, apopto-sis, and vasculogenic mimicry of tumor cells, which may contribute significantly to tumor growth inhibition. Restoration of TFPI-2 ex-pression in tumor tissue inhibits tumor growth and metastasis, which creates a novel possibility of cancer patient treatment. This review focuses on the expression and the molecular regulation mechanisms of TFPI-2 in malignant tumors that control the functions of TFPI-2 in proliferation, apoptosis, and angiogenesis. Insight into these processes will improve our understanding of TFPI-2 and provide new ap-proaches for rational treatment strategies.